Total knee replacement in patients with diffuse villonodular synovitis
This paper reports a case of diffuse pigmented villonodular synovitis (DPVNS), associated with advanced gonarthrosis, submitted to total knee replacement. The patient had progressive pain and swelling. She had two previous surgeries, firstly arthroscopic
Lucio Flávio Biondi Pinheiro Júnior +3 more
doaj +1 more source
Pigmented Villonodular Synovitis Arising from Calcaneocuboid Joint in an Army Staff: A Case Report.
Adel Ebrahimpour +4 more
openalex +2 more sources
Pigmented Villonodular Synovitis of Ankle Joint - A Case Report. [PDF]
Sahu SK, Parichha K, Dash A, Mishra NR.
europepmc +1 more source
Knee tuberculosis masquerading as pigmented villonodular synovitis
Tuberculosis (TB), once a disease confined to undeveloped or developing nations is currently in resurgence, which is attributable to pandemic human immunodeficiency virus (HIV) infection and immigration from endemic areas.
Sanjay Meena, Shreesh Kumar Gangary
doaj
Expression of colony-stimulating factor 1 is associated with occurrence of osteochondral change in pigmented villonodular synovitis [PDF]
Takehiro Ota +8 more
openalex +1 more source
Rice bodies associated with rheumatoid arthritis [PDF]
Anisau, Aliaksandr +2 more
core +2 more sources
Pigmented villonodular synovitis associated with pathological fracture of the odontoid and atlantoaxial instability [PDF]
Journal ArticlePPigmented villonodular synovitis (PVNS) is a proliferative disorder of the synovium with a predisposition for the appendicular skeleton.
Finn, Michael A., Schmidt, Meic H.
core
Clinical Outcomes of Endoscopic Synovectomy With Adjuvant Radiotherapy of Pigmented Villonodular Synovitis of The Hip: A Case Series of Single Center [PDF]
Hao Sun +4 more
openalex +1 more source
RADIOTHERAPY FOR PIGMENTED VILLONODULAR SYNOVITIS: A CASE REPORT
This is a case report of a 13 year old boy who has been operated for Pigmented Villonodular Synovitis (PVNS) and treated with adjuvant post-operative radiotherapy for incomplete surgical resection.
Navin Nayan, Vikas K Jagat
doaj
Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors. [PDF]
Purpose:To evaluate the safety, recommended phase II dose (RP2D) and efficacy of pexidartinib, a colony stimulating factor receptor 1 (CSF-1R) inhibitor, in combination with weekly paclitaxel in patients with advanced solid tumors.
Coussens, Lisa M +12 more
core

